STAT+: At AASLD, optimism about AI, Hep delta and Madrigal’s MASH drug
This is the online version of AASLD in 30 Seconds, the latest from the American Association for the Study of Liver Diseases’s Liver Meeting. Sign up here to get it in your inbox. Good